MedTrace Logo

BIO-FUNCTION for Prediction Non Relapse Mortality in Transplant and Cell Therapy

NCT07769151 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 124

Last updated 2026-08-17

No results posted yet for this study

Summary

The purpose of this research is test if combination of physical tests and blood tests drawn before SCTCT can predict NRM.

Conditions

  • Mortality Prediction

Interventions

DIAGNOSTIC_TEST

blood sample to check CXCL9 pre stem cell transplant and cell therapy

Pre SCTCT as per SOC physical function assessment will be performed in a form of IADl, hand grip, and or walk test like TUG. Specimen Collection Studies: LDH , albumin, ferritin, CRP, platelet and creatinine will be collected as per standard of care pre SCTCT. The non-SOC procedure will be drawing CXL9

Sponsors & Collaborators

  • Henry Ford Health System

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2030-12-30
Completion
2031-12-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07769151 on ClinicalTrials.gov